Angiotensin receptor blockers (ARBs) v placebo or angiotensin converting enzyme inhibitors (ACEIs) in heart failure at 4 weeks to 1.5 years*
| Outcomes | ARBs | ACEIs or placebo | RRR (95% CI) | NNT (CI) |
|---|---|---|---|---|
| Death | 13% | 15% | 4% (–19 to 22) | Not significant |
| Hospital admission | 14% | 17% | 12% (–5 to 27) | Not significant |
| ARBs and ACEIs | ACEIs | |||
|---|---|---|---|---|
| *Abbreviations defined in glossary; RRR, NNT, and CI calculated from data in article by using random effects. | ||||
| Hospital admission | 13% | 17% | 22% (12 to 32) | 26 (19 to 49) |